The Beijing Municipal Medical Insurance Bureau has released a notification indicating that a total of 923 medical entities are now designated for coverage under the National Reimbursement Drug List (NRDL). The document is open for public feedback from September 19 to September 26.
Designated Entities
Among the designated entities are 169 medical institutions, including 110 village clinics and 754 designated pharmacies. This expansion aims to enhance access to essential medications and improve healthcare services for residents in the region.
Future Outlook
The designation of these medical entities under the NRDL is expected to streamline the reimbursement process for prescribed medications, ensuring that patients have better access to necessary treatments. The public feedback period provides an opportunity for stakeholders to voice their opinions and contribute to the refinement of the policy.-Fineline Info & Tech
